These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 538649)

  • 1. Actions of VIP, somatostatin, and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro.
    Lonovics J; Devitt P; Rayford PL; Thompson JC
    Surg Forum; 1979; 30():407-9. PubMed ID: 538649
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure.
    Ryan J; Cohen S
    Gastroenterology; 1977 Oct; 73(4 Pt 1):870-2. PubMed ID: 892388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholecystokinine on the gallbladder motility: interaction with somatostatin and vasoactive intestinal peptide.
    Milenov K; Rakovska A; Kalfin R
    Acta Physiol Pharmacol Bulg; 1995; 21(3):67-76. PubMed ID: 8868369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
    Ryan JP; Ryave S
    Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of some drugs and peptide hormones on the responsiveness of the rabbit isolated gall-bladder to cholecystokinin.
    Johnson AG; Marshall CE; Wilson IA
    J Physiol; 1982 Nov; 332():415-25. PubMed ID: 7153934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin inhibits cholecystokinin-induced contraction of isolated gallbladder smooth muscle cells.
    Yamasaki T; Chijiiwa K; Chijiiwa Y
    J Surg Res; 1995 Dec; 59(6):743-6. PubMed ID: 8538175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of pancreatic polypeptide and motilin on contractility of human gallbladder.
    Pomeranz IS; Davison JS; Shaffer EA
    Dig Dis Sci; 1983 Jun; 28(6):539-44. PubMed ID: 6861584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of vasoactive intestinal polypeptide and cholecystokinin octapeptide on the control of gallbladder contraction.
    Strah KM; Melendez RL; Pappas TN; Debas HT
    Surgery; 1986 Apr; 99(4):469-73. PubMed ID: 3952671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gallbladder contractions induced by motilin and cholecystokinin in dogs.
    Takahashi I; Suzuki T; Aizawa I; Itoh Z
    Gastroenterology; 1982 Mar; 82(3):419-24. PubMed ID: 6274735
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of gastrointestinal hormones on concentrating function and motility in the gallbaldder. An experimental study in the cat.
    Jansson R
    Acta Physiol Scand Suppl; 1978; 456():1-38. PubMed ID: 278473
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of bombesin on the canine gallbladder motility: in vivo and in vitro experiments.
    Shahbazian A; Raichev P; Sandeva R; Kalfin R; Milenov K
    Acta Physiol Pharmacol Bulg; 1998; 23(2):39-45. PubMed ID: 10347619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key residues that cause differential gallbladder response to PACAP and VIP in the guinea pig.
    Wei M; Fujiki K; Ando E; Zhang S; Ozaki T; Ishiguro H; Kondo T; Nokihara K; Wray V; Naruse S
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G76-83. PubMed ID: 16901992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of substance P on contractions of the gallbladder.
    Mate L; Sakamoto T; Greeley GH; Thompson JC
    Surg Gynecol Obstet; 1986 Aug; 163(2):163-6. PubMed ID: 2426812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocrine regulation of exocrine pancreas in preruminant milk-fed calves.
    Davicco MJ; Lefaivre J; Barlet JP
    Ann Rech Vet; 1980; 11(2):123-32. PubMed ID: 6109515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of vasoactive intestinal polypeptide (VIP) on the canine gallbladder motility.
    Kalfin R; Milenov K
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 100(3):513-7. PubMed ID: 1687549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat.
    Jansson R; Steen G; Svanvik J
    Gastroenterology; 1978 Jul; 75(1):47-50. PubMed ID: 401095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of canine gallbladder motility by brain peptides.
    Lenz HJ; Zimmerman FG; Messmer B
    Gastroenterology; 1993 Jun; 104(6):1678-85. PubMed ID: 8500726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
    Hara N; Yosida T; Said SI
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec; 16(11):840-5. PubMed ID: 739695
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on neurotensin. I. Effects on gallbladder motility.
    Fujimura M
    Nihon Geka Hokan; 1989 Sep; 58(5):405-13. PubMed ID: 2642264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.